Escherichia coli BTC, a human cytochrome P450 competent tester strain with a high sensitivity towards alkylating agents: Involvement of alkyltransferases in the repair of DNA damage induced by aromatic amines

Mutagenesis

Volumn 20, Issue 3, 2005, Pages 199-208

  Duarte, Maria Paula ^a,b   Palma, Bernardo Brito ^a   Laires, António ^a,b   Oliveira, José Santos ^b   Rueff, José ^a   Kranendonk, Michel ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOANTHRACENE; 2 FLUORENYLAMINE; 2 NITROANTHRACENE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4 BIPHENYLAMINE; ALKYLATING AGENT; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 2E1; DIETHYLNITROSAMINE; DIPROPYLNITROSAMINE; METHYLNITRONITROSOGUANIDINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; BACTERIAL STRAIN; BIOTRANSFORMATION; DNA REPAIR; ENZYME ACTIVITY; ENZYME MECHANISM; ESCHERICHIA COLI; HUMAN; HUMAN CELL; KNOCKOUT GENE; MICROBIAL ACTIVITY; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ALKYL AND ARYL TRANSFERASES; ALKYLATING AGENTS; AMINES; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; DNA; DNA DAMAGE; DNA REPAIR; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; LIVER; METHYLTRANSFERASES; MUTAGENICITY TESTS; MUTAGENS; MUTATION; NADPH-FERRIHEMOPROTEIN REDUCTASE; PEPTIDE FRAGMENTS; RATS;

ADA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 19544372412     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/gei028     Document Type: Article

References (49)

1. Autrup,H. (2000) Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res., 464, 65-76.
2. Gonzalez,F.J. and Gelboin,H.V. (1994) Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev., 26(1&2), 165-183.
3. Kranendonk,M., Laires,A., Rueff,J., Estabrook,R.W. and Vermeulen,N.P.E. (2000) Heterologous expression of xenobiotic mammalian-metabolizing enzymes in mutagenicity tester bacteria: an update and practical considerations. CRC Crit. Rev. Toxicol., 30(3), 287-306.
4. Guengerich,F.P., Wheeler,J.B., Chun,Y., Kim,D., Shimada,T., Aryal,P., Oda,Y. and Gillam,E.M.J. (2002) Use of heterologously-expressed cytochrome P450 and glutathione transferase enzymes in toxicity assays. Toxicology, 181-182, 261-264.
5. Rueff,J., Gaspar,J. and Kranendonk,M. (2002) DNA polymorphisms as modulators of genotoxicity and cancer. Biol. Chem., 383, 923-932.
6. Josephy,P.D. (2002) Genetically-engineered bacteria expressing human enzymes and their use in the study of mutagens and mutagenesis. Toxicology, 181-182, 255-260.
7. Guengerich,F.P. (1998) The environmental genome project: functional analysis of polymorphisms. Envir. Health Perspect., 106, 365-368.
8. Olden,K. and Wilson,S. (2000) Environmental health and genomics: vision and implications. Nat. Genet. Rev., 1, 149-153.
9. Orphanides,G. and Kimber,I. (2003) Toxicogenetics: applications and opportunities. Toxicol. Sci., 75, 1-6.
10. Kranendonk,M., Fisher,C.W., Roda.R., Carreira.F., Theisen.P., Laires,A., Rueff,J., Vermeulen,N.P.E. and Estabrook.R.W. (1999) Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450: comparison of three types of expression systems. Mutat. Res., 439, 287-300.
11. Kranendonk,M., Roda,R., Carreira,F., Theisen,P., Laires,A., Fisher,C.W., Rueff,J., Vermeulen,N.P.E. and Estabrook,R.W. (1999) Escherichia coli MTC, a human NADPH cytochrome P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4 or 3A5: catalytic activities and mutagenicity studies. Mutat. Res., 441, 73-83.
12. Kranendonk,M., Mesquita,P., Laires,A., Vermeulen,N.P.E. and Rueff,J. (1998) Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens. Mutagenesis, 13, 263-269.
13. 6- methylguanine DNA repair methyltransferase. J. Bacterial., 173(6), 2068-2076.
14. Lindahl,T., Sedgwick,B., Sekiguchi,M. and Nakabeppu,Y. (1988) Regulation and expression of the adaptive response to alkylating agents. Ann. Rev. Biochem., 57, 133-157.
15. 6-alkylguanine alkyltransferases. J. Biol. Chem., 272(13), 8332-8339.
16. 6-alkylguanine by alkyltransferases. Mutat. Res., 462, 83-100.
17. 6-alkylguanine-DNA alkyltransferase. J. Biol. Chem., 277(40), 37920-37928.
18. 6-alkylguanine-DNA alkyltransferase has opposing effects in modulating the genotoxicity of dibromomethane and bromomethyl acetate. Chem. Res. Toxicol., 17(6), 742-752.
19. Miller,J.H. (1972) Experiments in Molecular Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Maloy,S.R. and Nunn,W.D. (1981) Selection for loss of tetracycline resistance by Escherichia coli. J. Bacterial., 145(2), 1110-1112.
21. Kranendonk,M., Ruas,M., Laires,A. and Rueff,J. (1994) Isolation and prevalidation of an Escherichia coli tester strain for the use in mechanistic and metabolic studies of genotoxins. Mutat. Res., 312, 99-109.
22. Kranendonk,M., Pintado,F., Mesquita,P., Laires,A., Vermeulen,N.P.E. and Rueff,J. (1996) MX100, a new Escherichia coli tester strain for use in genotoxicity studies. Mutagenesis, 11, 327-333.
23. Sainbrook,J., Fritsch,T.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
24. Dong,J. and Porter,T.D. (1996) Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli. Arch. Biochem. Biophys., 327(2), 254-259.
25. Gillam,E.M.J., Guo,Z. and Guengerich,F.P. (1994) Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch. Biochem. Biophys., 312(1), 59-66.
26. Pearce,R.R., McIntyre,C.J., Madan,A. et al. (1996) Effects of freezing, thawing and storing human liver microsomes on cytochrome P450 activity. Arch. Biochem. Biophys., 2, 145-169.
27. Maron,D.M. and Ames,B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
28. Kranendonk,M., Commandeur,J.N., Laires,A. Rueff,J. and Vermeulen,N.P. (1997) Characterization of enzyme activities and cofactors involved in bioactivation and bioinactivation of chemical carcinogens in the tester strains Escherichia coli K12 MX100 and Salmonella typhimurium LT2 TA100. Mutagenesis, 12(4), 245-254.
29. 6-methylguanine DNA methyltransferases and highly sensitive to mutagenic alkylating agents. Mutat. Res., 381, 15-24.
30. Duarte,M.P., Palma,B.B., Gilep,A.A., Laires,A., Oliveira,J.S., Usanov,S.A., Rueff,J. and Kranendonk,M. (2005) The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6, and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation. Mutagenesis, 20, 93-100.
31. Fujita,K., Nakayama,K., Yamazaki,Y., Tsuruma,K., Yamada,M., Nohmi,T. and Kamataki,T. (2001) Construction of Salmonella typhimurium YG7108 strains, each coexpressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase. Environ. Mol. Mutagen., 38, 329-338.
32. Cooper,M.T. and Porter,T.D. (2000) Mutagenicity of nitrosamines in methyltransferase-deficient strains of Salmonella typhimurium coexpressing human cytochrome P450 2E1 and reductase. Mutat. Res., 454, 45-52.
33. Kushida,H., Fujita,K., Suzuki,A., Yamada,M., Nohmi,T. and Kamataki,T. (2000) Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines: expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S.typhimurium YG7108. Mutat. Res., 471, 135-143.
34. Kushida,H., Fujita,K., Suzuki,A., Yamada,M., Endo.T., Nohmi,T. and Kamataki,T. (2000) Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimirium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis, 21, 1227-1232.
35. Fujita,K. and Kamataki,T. (2001) Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase. Mutat. Res., 483, 35-41.
36. Fujita,K. and Kamataki,T. (2001) Predicting the mutagenicity of tobacco-related nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase. Environ. Mol. Mutagen., 38, 339-346.
37. Kamataki,T., Nunoya,K., Sakai,Y., Kushida,H. and Fujita,K. (1999). Genetic polymorphism of CYP2A6 in relation to cancer. Mutat. Res., 428, 125-130.
38. Crespi,C.L. and Miller,V.P. (1999) The use of heterologously expressed drug metabolizing enzymes - state of the art and prospects for the future. Pharmacol. Ther., 84, 121-131.
39. Paine,M.F., Khalighi,M., Fisher,J.M., Shen,D.D., Kunze,K.L., Marsh,C.L., Perkins,J.D. and Thummel,K.E. (1997) Characterization of interintestinal and intraintestinal variations in human CYP3A4-dependent metabolism. J. Pharmacol. Exp. Ther., 283, 1552-1562.
40. Venkatakrishnan,K., Von Moltke,L.L., Court,J.S., Harmatz,J.S., Crespi,C.L. and Greenblatt,D.J. (2000) Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between approaches. Drug Metab. Dispos., 28(12), 1493-1504.
41. Oda,Y., Yamazaki.H. and Shimada,T. (1999) Role of human N-acetyltransferases, NAT1 or NAT2, in genotoxicity of nitroarenes and aromatic amines in Salmonella typhimurium NM6001 and NM6002. Carcinogenesis, 20, 1079-1083.
42. Glatt,H., Pabel,U., Meinl,W., Frederiksen,H., Fradsen,H. and Muckel,E. (2004) Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9H- pyrido[2,3-b]indole (MeAaC) in recombinant test systems expressing human xenobiotic-metabolizing enzymes. Carcinogenesis, 25, 801-807.
43. Mackay,W.J., Han,S. and Samson,L.D. (1994) DNA alkylation repair limits spontaneous base substitution mutation in Escherichia coli. J. Bacterial., 176(11), 3224-3230.
44. Kawabe,M., Ward,J.M., Morishima,H., Kadlubar,F.F., Hammons,G.J., Kimura,S., Fernandez-Salguero,P. and Gonzalez,F.J. (1999) CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice. Carcinogenesis, 20, 1825-1830.
45. Yamazaki,H., Mimura,M., Oda,Y., Inui,Y., Shiraga,T., Iwasaki,K., Guengerich,F.P. and Shimada,T. (1993) Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes. Carcinogenesis, 14, 1271-1278.
46. Zhou,H., Josephy,P.D., Kim,D. and Guengerich,F.P. (2004) Functional characterization of four allelic variants of human cytochrome P450 1A2. Arch. Biochem. Biophys., 422, 23-30.
47. Le Motte,P.K. and Walker,G.C. (1985) Induction and auto-regulation of ada, a positively acting element regulating the response of Escherichia coli K12 to methylating agents. J. Bacteriol., 161, 888-895.
48. 6-methylguanine-DNA methyltransferases in DNA repair. Mutat. Res., 254, 37-44.
49. Fisher,C.W., Caudle,D.L., Martin-Wixtrom,C., Quattrochi,L.C., Tukey,R.H., Waterman,M.R. and Estabrook,R.W. (1992) High-level expression of functional human cytochrome P450 1A2 in Escherichia coli. FASEB J., 6(2), 759-764.